Article
MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People
“I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes.”
Russell Hausfeld is an investigative journalist and illustrator living in Cincinnati, Ohio. He has a Bachelor’s degree in Journalism and Religious Studies from the University of Cincinnati. His work with Psymposia has been cited in Vice, The Nation, Frontiers in Psychology, New York Magazine’s “Cover Story: Power Trip” podcast, the Daily Beast, the Outlaw Report, Harm Reduction Journal, and more.
Article
“I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes.”
Article
Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.
Article
Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.
Article
‘Debbie and Doug Drop Acid in the Desert’ director, Scott Brown, talks mind-altering drugs, creating psychedelic visual effects, and dealing with depression.
Article
Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.
Article
“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.
Article
A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.
Article
As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.
Article
Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.
Article
After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.
Article
The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.
Article
“Play the field right and there’s money to be made even off some of the shit companies purely based on the wave.”
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture. We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.